Want to join the conversation?
In the US Branded business, $ENDP secured FDA approval for BELBUCA, continued to drive growth for XIAFLEX and supported OPANA ER. In US Generics, the company closed the acquisition of Par achieving critical mass. Within International, $ENDP closed the Aspen portfolio acquisition for Litha Group which is now refocused on pharmaceuticals.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.